HRP20090054T3 - Piperazine derivatives of alkyl oxindoles - Google Patents

Piperazine derivatives of alkyl oxindoles

Info

Publication number
HRP20090054T3
HRP20090054T3 HR20090054T HRP20090054T HRP20090054T3 HR P20090054 T3 HRP20090054 T3 HR P20090054T3 HR 20090054 T HR20090054 T HR 20090054T HR P20090054 T HRP20090054 T HR P20090054T HR P20090054 T3 HRP20090054 T3 HR P20090054T3
Authority
HR
Croatia
Prior art keywords
alkyl
piperazine derivatives
halogen
oxindoles
alkyl oxindoles
Prior art date
Application number
HR20090054T
Other languages
English (en)
Croatian (hr)
Inventor
Volk Bal�zs
Bark�czy J�zsef
Simig Gyula
Mezei Tibor
Kapillern� Dezsofi Rita
Gacs�lyi Istv�n
Pallagi Katalin
Gigler G�bor
L�vay Gy�rgy
M�ricz Krisztina
Leveleki Csilla
Sziray N�ra
Sz�n�si G�bor
Egyed Andr�s
G�bor H�rsing L�szl�
Original Assignee
EGIS Gy�gyszergy�r Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU0400954A external-priority patent/HU0400954D0/hu
Priority claimed from HU0500461A external-priority patent/HUP0500461A3/hu
Application filed by EGIS Gy�gyszergy�r Nyrt filed Critical EGIS Gy�gyszergy�r Nyrt
Publication of HRP20090054T3 publication Critical patent/HRP20090054T3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
HR20090054T 2004-05-11 2009-01-29 Piperazine derivatives of alkyl oxindoles HRP20090054T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0400954A HU0400954D0 (en) 2004-05-11 2004-05-11 Piperazine derivatives of alkyl oxindoles
HU0500461A HUP0500461A3 (en) 2005-05-05 2005-05-05 Pyperazine derivatives of alkyl-oxindoles
PCT/HU2005/000048 WO2005108363A1 (en) 2004-05-11 2005-05-10 Piperazine derivatives of alkyl oxindoles

Publications (1)

Publication Number Publication Date
HRP20090054T3 true HRP20090054T3 (en) 2009-03-31

Family

ID=89985994

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20060401A HRP20060401A2 (en) 2004-05-11 2006-11-20 Piperazine derivatives of alkyl oxindoles
HR20090054T HRP20090054T3 (en) 2004-05-11 2009-01-29 Piperazine derivatives of alkyl oxindoles

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HR20060401A HRP20060401A2 (en) 2004-05-11 2006-11-20 Piperazine derivatives of alkyl oxindoles

Country Status (24)

Country Link
US (1) US20070219209A1 (xx)
EP (1) EP1751106B1 (xx)
JP (1) JP2007537226A (xx)
KR (1) KR20070011551A (xx)
AT (1) ATE412634T1 (xx)
AU (1) AU2005240842B2 (xx)
BG (1) BG109768A (xx)
CA (1) CA2564009A1 (xx)
CZ (1) CZ2006778A3 (xx)
DE (1) DE602005010694D1 (xx)
DK (1) DK1751106T3 (xx)
EA (1) EA011280B1 (xx)
ES (1) ES2317241T3 (xx)
HR (2) HRP20060401A2 (xx)
IL (1) IL178759A0 (xx)
MX (1) MXPA06013064A (xx)
NO (1) NO20065697L (xx)
NZ (1) NZ551542A (xx)
PL (1) PL1751106T3 (xx)
PT (1) PT1751106E (xx)
RS (1) RS20060620A (xx)
SI (1) SI1751106T1 (xx)
SK (1) SK51112006A3 (xx)
WO (1) WO2005108363A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007537229A (ja) * 2004-05-11 2007-12-20 エギシュ ヂョヂセルヂャール エンニュ・エル・テー ジアルキルオキシインドールの新規なピペラジン誘導体
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
WO1998008816A1 (fr) * 1996-08-26 1998-03-05 Meiji Seika Kaisha, Ltd. Derives d'indoxyle et psychotropes

Also Published As

Publication number Publication date
ES2317241T3 (es) 2009-04-16
PT1751106E (pt) 2009-02-10
MXPA06013064A (es) 2007-04-27
ATE412634T1 (de) 2008-11-15
US20070219209A1 (en) 2007-09-20
EA011280B1 (ru) 2009-02-27
DE602005010694D1 (de) 2008-12-11
KR20070011551A (ko) 2007-01-24
SI1751106T1 (sl) 2009-06-30
PL1751106T3 (pl) 2009-07-31
EP1751106A1 (en) 2007-02-14
EA200602080A1 (ru) 2007-04-27
DK1751106T3 (da) 2009-03-09
SK51112006A3 (sk) 2007-05-03
AU2005240842A1 (en) 2005-11-17
BG109768A (bg) 2008-03-31
JP2007537226A (ja) 2007-12-20
NZ551542A (en) 2010-06-25
IL178759A0 (en) 2007-02-11
EP1751106B1 (en) 2008-10-29
CZ2006778A3 (cs) 2007-03-07
CA2564009A1 (en) 2005-11-17
RS20060620A (xx) 2008-09-29
AU2005240842B2 (en) 2011-10-06
HRP20060401A2 (en) 2007-03-31
WO2005108363A1 (en) 2005-11-17
NO20065697L (no) 2007-02-02

Similar Documents

Publication Publication Date Title
RS51994B (en) DERIVATI PIRIDAZINA
DK1856045T3 (da) 1-eddikesyreindolderviater med PGD2-antagonisteffekt
RS50437B (sr) Benzoilpirazoli i njihova primena u ulozi herbicida
RS54260B1 (en) AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT
RS50519B (sr) Supstituisani derivati 8'-piri(mi)dinil-dihidrospiro- /cikloalkilamin/-pirimido/1,2-a/pirimidin-6-ona
RS50606B (sr) Supstituisani morfolin i tiomorfolin derivati
HRP20040429B1 (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
RS53379B (en) N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES AND THE PROCEDURE FOR THEIR PREPARATION
CO5310534A1 (es) Nuevos derivados de androstano anti-inflamatorios
MEP10709A (en) 2-ARYL-6-PHENYLIMIDAZO[1,2-alpha]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
RS52119B (en) 4-phenylamino-HINAZOLIN-6-IL-STARCHES
HRP20080477T3 (en) Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors
HRP20090151T3 (en) Indozolone derivatives as 11b-hsd1 inhibitors
CO5031241A1 (es) Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
RS53348B (en) PROCEDURE FOR THE PREPARATION OF 3-SUBSTITUTED 2-AMINO-5-HALOBENZAMIDES
RS52562B (en) (3-ARIL-PIPERAZINE-1-IL) DERIVATI 6,7-DIALCOKSIQUINZOLINE, 6,7-DIALCOKSIFTALAZINE I
RS53080B (en) AMINOPHOSPHORIC ACID ETHAR DERIVATIVE AND S1P RECEPTOR MODULATOR CONTAINING THE SAME AS THE ACTIVE INGREDIENT
HRP20050213A2 (en) 2,4-substituted indoles and their use as 5-ht6 modulators
EP1490371A4 (en) TRICYCLIC COMPOUNDS BASED ON THIOPENE AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUNDS
RS51674B (en) PIPERIDIN-4-IL-PIRIDAZIN-3-ILAMINE DERIVATIVES AS A FAST DISSOCATING DOPAMIN 2 RECEIVER ANTAGONISTS
MEP24208A (en) Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
RS50628B (sr) Derivati(poli)aminoacetamida epipodofilotoksina, postupak za njihovo dobijanje i njihove primene u terapeutici kao sredstva protiv kancera
ATE409179T1 (de) Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten